SavedAdd your journal

Journals / Journal of Health Sciences and Medicine / 2022 / Cilt: 5 - Sayı: 3

Clinical, sonographical and cytological comparison of toxic and non-toxic thyroid nodules

Zeynep ÇETİN
Derya KÖSEOĞLU
Özden ÖZDEMİR BAŞER
Pages
922–925
Publication Date
2022-05-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Central vascularization (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To compare patients with toxic and non-toxic nodular/multinodular goiter in terms of clinical, sonographical and cytological features.
📊
Key Findings & Data:Material and Method: The medical data of 326 patients were reviewed retrospectively.
💡
Conclusion & Impact:Central vascularization (p
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Thyroid nodule · toxic · sonography

Abstract

Aim: To compare patients with toxic and non-toxic nodular/multinodular goiter in terms of clinical, sonographical and cytological features. Material and Method: The medical data of 326 patients were reviewed retrospectively. Clinical and sonographic features were examined. Four hundred and eighty-one nodules were compared sonographically and cytologically. One hundred twenty-four patients had toxic nodular goiter and 202 of them had non-toxic nodular goiter. Results: The toxic nodular goiter group was older, they had more male sex, more multi-nodularity, larger thyroid glands and nodules with more sonographically suspicious features (p 40 mm in 13.9% of the nodules in the toxic group and 5.4% of those in the non-toxic group (p= 0.003). Central vascularization (p

🔖

Cite This Article

ÇETİN, Z., KÖSEOĞLU, D., BAŞER, Ö. Ö. (2022). Clinical, sonographical and cytological comparison of toxic and non-toxic thyroid nodules. Journal of Health Sciences and Medicine, Cilt: 5 - Sayı: 3, 922–925. https://ajindex.com/articles/776569

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Gilbert J. Thyrotoxicosis – investigation and management. Clin Med (Lond) 2017; 17: 274-7.
  2. Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011; 21: 593-646.
  3. Fiore E, Rago T, Provenzale MA. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocr Relat Cancer 2019; 16: 1251-60. Mandel SJ. A 64-year-old woman with a thyroid nodule. JAMA 2004; 292: 2632-42.
  4. Maia FFR, Zantut-Wittmann DE. Thyroid nodule management: clinical, ultrasound and cytopathological parameters for predicting malignancy. CLINICS 2012; 67: 945-54.
  5. Eng CY, Quraishi MS, Bradley PJ. Management of thyroid nodules in adult patients. Head Neck Oncol 2010; 2: 1–5.
  6. Tam AA, Ozdemir D, Alkan A, et al. Toxic nodular goiter and thyroid cancer: Is hyperthyroidism protective against thyroid cancer? Surgery 2019; 166: 356-61.
  7. Baser H, Topaloglu O, Bilginer MC, et al. Are cytologic and histopathologic features of hot thyroid nodules different from cold thyroid nodules? Diagn Cytopathol 2019; 47: 898-903.
  8. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016; 26: 1-133.
  9. Cibas E, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid 2017; 27: 1341-6.
  10. De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet 2016; 388: 906–18.
  11. LiVolsi VA, Baloch ZW. The pathology of hyperthyroidism. Front Endocrinol (Lausanne) 2018; 9: 737. Knobel M. Etiopathology, clinical features, and treatment of diffuse and multinodular nontoxic goiters. J Endocrinol Invest 2016; 39: 357. Medeiros-Neto G. Multinodular goiter. Feingold KR, Anawalt B, Boyce A, eds. In: Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–16.
  12. Abraham-Nordling M, Torring O, et al. Graves’ disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery. Thyroid 2005; 15:1279–86.
  13. Rosario PW, Rocha TG, Mourão GF, Calsolari MR. Is radioiodine scintigraphy still of value in thyroid nodules with indeterminate cytology?: a prospective study in an iodin